Study to Evaluate the Safety of AT2220 (Duvoglustat) in Pompe Disease
Clinical trial NCT00688597 · TERMINATED
Trial details
- NCT number
- NCT00688597
- Sponsor
- Amicus Therapeutics
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-12-08
- Primary completion
- 2009-12-14
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.